|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mannatech Inc. (MTEX—NASDAQ) reported a net loss of $4.8 million or 18 cents per diluted share for the first quarter ending Mar. 31, 2009, compared to a net loss of $2.3 million or 9 cents per diluted share for the first quarter of 2008. Operating results were negatively impacted by higher commissions paid while in transition to a new lower-priced business builder pack and continuing unfavorable foreign currency exchange.
First-quarter net sales for 2009 were $70.7 million, a decrease of 22.7 percent, compared to $91.5 million in the first quarter of 2008. The sales decline was largely due to a 27.6 percent decrease in North American sales compared to the first quarter of 2008. International sales decreased 14.3 percent for the first quarter of 2009 compared to the first quarter of 2008, partially due to the negative impact of a stronger U.S. dollar in the first quarter compared to the first quarter of 2008. The stronger U.S. dollar negatively impacted sales by $4.3 million, excluding South Africa.
New independent associate recruiting totaled 36,465 in the first quarter of 2009, compared to 34,383 new associates added in the fourth quarter of 2008 and 28,838 new associates added in the third quarter of 2008. Total independent associate and member count based on a 12-month trailing period was 527,000 for the first quarter of 2009 as compared to 570,000 for the first quarter of 2008.
Mannatech Inc. is a global wellness-solutions provider of innovative, high-quality, proprietary dietary supplements, skincare products, and weight and fitness products sold through independent associates and members worldwide.
RBC Life Sciences Inc. (RBCL—OTC BB) reported that U.S. and Canadian sales of the company’s nutritional supplements and body-care products increased to $1.49 million during the first quarter of 2009 compared to $1.47 million during the first quarter of 2008. The company’s MPM Medical Inc. brand sa
w its wound-care and pain-management products sales increase 10 percent to $1.5 million during the first quarter of this year compared to $1.36 million during the same quarter of 2008.
RBC Life Sciences reported companywide net sales of $6.02 million for the quarter ended March 31, 2009, compared to net sales of $6.35 million for the same quarter last year. The company also reported a net loss of $171,000, or 1 cent per share, during the first quarter of 2009 compared to net earnings of $355,000, or 2 cents per share, in 2008.
RBC Life Sciences added approximately 2,000 new independent associates since launching its domestic network marketing rebuilding effort in November 2008.
RBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal-care products to a growing population of consumers seeking wellness and a healthy lifestyle.
The Amacore Group Inc. (ACGI—OTC BB) reported that revenue for the first quarter ending March 31, 2009, increased 48 percent over the first quarter of 2008 to $7.4 million, compared with $5.0 million for the first quarter of 2008. Gross profit for the first quarter of 2009 improved to $2.8 million, compared with gross profit of $1.0 million for the first quarter of 2008. Operating expenses for the first quarter of 2009 were $7.5 million, compared with operating expenses of $5.9 million for the first quarter of 2008.
The company’s operating loss for the first quarter of 2009 was $4.7 million, compared with an operating loss of $4.9 million in the first quarter of 2008. The company reported net income available to common stockholders for the quarter of $1.4 million, or zero cents per share, compared with a net loss available to common stockholders of $13.6 million, or 10 cents per share, in the prior year’s quarter.
The Amacore Group Inc. is primarily a provider and marketer of healthcare-related products, including healthcare benefits, vision and dental networks, and administrative services such as billing, fulfillment, patient advocacy, claims administration and servicing. Zurvita, its multilevel marketing subsidiary, is a provider of products and benefits in health care and other niche markets.
XELR8 Holdings Inc.
XELR8 Holdings Inc. (XELR—OTC BB) announced its net revenue for the first quarter ended March 31, 2009 was $1.3 million, a 17 percent decrease compared to net revenue of $1.6 million for the first quarter ended March 31, 2008. Gross profit declined to $1.0 million for the three-months ended March 31, 2009, down 20 percent from $1.2 million in the prior-year period. Gross margin in the quarter was 75 percent, as compared to 77 percent in the same quarter one year ago. Net loss for the three-months ended March 31, 2009, improved 15 percent to $0.64 million, or 4 cents per share, compared to a loss of $0.75 million, or 5 cents per share, in the prior year.
XELR8 Holdings Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand and that fit conveniently within a lifestyle.
YTB International Inc. (YTBLA—OTC BB) announced its total revenue for the quarter ended March 31, 2009, decreased 49 percent to $21.8 million, compared to $42.7 million for the first quarter of 2008. Net loss for the quarter ended March 31, 2009, was $1.9 million, or 2 cents per diluted share, compared to a net loss of $3.5 million, or 3 cents per diluted share, for the same period of 2008. General and administrative expenses decreased by $3.4 million, or 23 percent, compared to the same period of 2008, primarily attributable to the company’s cost-reduction program.
YTB International Inc. provides Internet-based travel-booking services for home-based independent representatives in the United States, Puerto Rico, the Bahamas, Canada, Bermuda and the U.S. Virgin Islands. The company operates through three subsidiaries: YourTravelBiz.com Inc., YTB Travel Network Inc. and REZconnect Technologies Inc.
Natural Health Trends Corp. (BHIP—NasdaqCM) reported sales of $9.9 million and an operating loss of $808,000 for the quarter ending March 31, 2009.
Natural Health Trends Corp. is an international direct selling and e-commerce company operating through its subsidiaries throughout Asia, North America and Europe. The company markets premium-quality personal-care products under the NHT Global brand.
GeneLink Inc. (GNLK.OB—OTCBB) reported the net sales for the fiscal 2009 three-month period ended March 31, 2009, were $2.0 million, as compared to $26,000 for the same period in 2008. The quarterly gross profit was $1.05 million in the first quarter of 2009, compared to $1,109 for the first quarter of 2008. Operating losses reduced to $470,474 from $503,106 for the previous quarter, ended Dec. 31, 2008. The company completed fundraising, exceeding $2.6 million.
GeneLink is a leading biosciences company specializing in consumer genomics. GeneWize, GeneLink’s wholly owned subsidiary, is a direct sales company focusing exclusively on providing individually customized nutritional and skincare formulations based on a consumer’s personal genetic assessment. The company empowers individuals to take personal responsibility and control of their health.
